CLINICAL AND RADIOGRAPHIC EFFICACY OF SARILUMAB PLUS METHOTREXATE IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL STUDY

被引:0
|
作者
van der Heijde, D. [1 ]
Genovese, M. C. [2 ]
Fan, C. [3 ]
Fiore, S. [3 ]
Decktor, D. L. [4 ]
Fleischmann, R. [5 ,6 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[3] Sanofi, Bridgewater, MA USA
[4] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[5] Metroplex Clin Res Ctr, Dallas, TX USA
[6] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
关键词
D O I
10.1136/annrheumdis-2015-eular.4772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0185
引用
收藏
页码:722 / 722
页数:1
相关论文
共 50 条
  • [1] Clinical and Radiographic Efficacy of Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naive Patients with Rheumatoid Arthritis in a Phase 3, Randomized, Double-blind, Placebo-Controlled Study
    Fiore, Stefano
    Genovese, Mark
    Fan, Chunpeng
    Decktor, Dennis
    Fleischmann, Roy
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1217 - 1217
  • [2] Comparable Efficacy with Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naive Patients with Moderate-to-Severe Rheumatoid Arthritis from a Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study.
    Fleischmann, Roy
    Decktor, Dennis L.
    Fan, Chunpeng
    Van Hoogstraten, Hubert
    Genovese, Mark C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1232 - S1233
  • [3] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [4] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [5] A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study.
    Kavanaugh, Arthur
    Decktor, Dennis L.
    Fan, Chunpeng
    van Adelsberg, Janet
    Martincova, Renata
    Genovese, Mark C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1233 - S1234
  • [6] EFFICACY AND SAFETY OF SARILUMAB PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS AND IN THOSE WHO ARE BIOLOGIC-NAIVE
    Fleischmann, Roy
    Genovese, Mark
    Fan, Chunpeng
    Fiore, Stefano
    Decktor, Dennis
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 122 - 122
  • [7] EFFICACY AND SAFETY OF GUSELKUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE AXIAL PSORIATIC ARTHRITIS: STUDY DESIGN OF A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Gladman, D. D.
    Mease, P. J.
    Bird, P.
    Soriano, E.
    Chakravarty, S. D.
    Shawi, M.
    Xu, S.
    Quinn, S.
    Gong, C.
    Leibowitz, E.
    Tam, L. S.
    Helliwell, P.
    Kavanaugh, A.
    Deodhar, A.
    Ostergaard, M.
    Baraliakos, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1574 - 1575
  • [8] Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study
    Matsubara, Tsukasa
    Inoue, Hiroshi
    Nakajima, Toshihiro
    Tanimura, Kazuhide
    Sagawa, Akira
    Sato, Yukio
    Osano, Kei
    Nagano, Shuji
    Ueki, Yukitaka
    Hanyu, Tadamasa
    Hashizume, Koichi
    Amano, Norihito
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    [J]. RMD OPEN, 2018, 4 (02):
  • [9] EFFECTS OF SARILUMAB PLUS MTX ON CLINICAL, RADIOGRAPHIC, AND FUNCTIONAL ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY
    Genovese, M.
    Fleischmann, R. M.
    Kivitz, A. J.
    Rell-Bakalarska, M.
    Martincova, R.
    Fiore, S.
    Rohane, P.
    van Hoogstraten, H.
    Fan, C.
    van Adelsberg, J.
    Weinstein, S.
    Graham, N.
    Stahl, N.
    Yancopoulos, G.
    Huizinga, T. W.
    van der Heijde, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 70 - 70
  • [10] Efficacy and safety of Guselkumab through 2 years: Results from a phase 3, randomized, double-blind, placebo-controlled study conducted in biologic-naive patients with active psoriatic arthritis
    McInnes, I.
    Rahman, P.
    Gottlieb, A.
    Hsia, E.
    Kollmeier, A.
    Xu, X.
    Sheng, S.
    Jiang, Y.
    Shawi, M.
    Chakravarty, S.
    van der Heijde, D.
    Mease, P.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 : 38 - 38